Protein and RNA quantitation analyses of primary tumor samples have shown that HER2 and ESR1 expression are anti-correlated in HER2+ tumors, while they tend to be uncorrelated or even positively correlated in HER2- tumors [36]. The gene discussed is ESR1; the disease is neoplasm.